Intellectual Property and Freedom-to-Operate (IP/FTO) Analysis

The contract involves conducting intellectual property (IP) landscape and freedom-to-operate (FTO) assessments specifically focused on AI-designed antiviral compounds and platforms. The goal is to evaluate these innovations for commercial viability while ensuring that their development and use do not infringe on existing patents or intellectual property rights. This assessment will help guide strategic decisions in the development and commercialization process by identifying potential IP risks and opportunities. Issued by the Department of Health and Human Services under the Administration for Strategic Preparedness and Response, this subcontract falls under NAICS code 541690, which covers other scientific and technical consulting services. The solicitation was posted on May 19, 2026, with a response deadline of July 17, 2026. While no geographical or organization-specific details were provided for the place of performance or contractor type, the subcontract aims to provide critical IP analysis to support innovation in antiviral technology, helping to ensure that new AI-driven therapies can be developed without legal obstacles.